David Weingeist

Company: Johnson & Johnson Innovative Medicine

Job title: Scientific Director, Oncology Diagnostics Leader

Seminars:

Revolutionizing Early Bladder Cancer Detection with Urine-Based Genomic Liquid Biopsies 1:40 pm

Utilizing urine samples for patient screening, providing a reliable and patient-friendly alternative that addresses the challenges associated with tissue and plasma-based testing Employing a highly sensitive genomic method capable of identifying a broad spectrum of genetic alterations Leveraging the robust detection capabilities of urine-based assays to facilitate earlier diagnosis and more personalized treatment strategiesRead more

day: Day Two Track A (PM)